Provided by Tiger Fintech (Singapore) Pte. Ltd.

Senti Biosciences, Inc.

3.25
-0.0700-2.11%
Post-market: 3.17-0.0799-2.46%17:31 EDT
Volume:87.05K
Turnover:286.67K
Market Cap:84.51M
PE:-0.27
High:3.44
Open:3.33
Low:3.11
Close:3.32
Loading ...

Biotech Alert: Searches spiking for these stocks today

TipRanks
·
5 hours ago

Senti Bio Releases Virtual Investor “What This Means” Segment

GlobeNewswire
·
Yesterday

Senti Bio to Present at the Citizens JMP Life Sciences Conference

GlobeNewswire
·
30 Apr

Top Midday Decliners

MT Newswires Live
·
29 Apr

Senti Biosciences Pauses Enrollment in Hepatocellular Carcinoma Trial in China; Shares Fall

MT Newswires
·
29 Apr

Senti Bio's SENTI-202, A First-In-Class Off-The-Shelf Logic Gated Selective CD33 OR FLT3 NOT EMCN CAR NK Cell Therapy, Demonstrates Positive Preliminary Clinical Results In The Treatment Of Pati

Reuters
·
28 Apr

Senti Bio’s SENTI-202, a First-in-Class Off-the-Shelf Logic Gated Selective CD33 OR FLT3 NOT EMCN CAR NK Cell Therapy, Demonstrates Positive Preliminary Clinical Results in the Treatment of Patients with Relapsed/Refractory AML

GlobeNewswire
·
28 Apr

Senti Bio to Host Conference Call and Webcast to Discuss SENTI-202 Clinical Data Being Presented at the American Association for Cancer Research (AACR) Annual Meeting 2025 on Monday, April 28th at 8:30 AM ET

GlobeNewswire
·
24 Apr

Senti Bio Participates in a Virtual Investor KOL Connect Segment

GlobeNewswire
·
21 Apr

Senti Bio (NASDAQ: SNTI) to Participate in a Live Virtual Investor Closing Bell Segment

GlobeNewswire
·
16 Apr

Press Release: Senti Bio Bolsters Scientific Advisory Board with Appointment of James B. Trager, Ph.D.

Dow Jones
·
10 Apr

Senti Bio joins Webull Corporate Connect Service platform

TIPRANKS
·
07 Apr

Senti Bio to Showcase SENTI-202 Clinical Data and Novel Logic Gated Gene Circuit Mechanism of Action in Oral and Poster Presentations at the American Association for Cancer Research (AACR) Annual Meeting 2025

GlobeNewswire
·
03 Apr

Senti Biosciences Files Shelf for 52.9 Million Shares

MT Newswires Live
·
21 Mar

BRIEF-Senti Biosciences Inc Files For Mixed Shelf Of Up To $300 Million – SEC Filing

Reuters
·
21 Mar

Senti Biosciences : Sales Agreement Prospectus Covering Offering of up to $17.5 Mln Common Stock That May Be Issued Under Sales Agreement

THOMSON REUTERS
·
21 Mar

Senti Biosciences Inc Files for Mixed Shelf of up to $300 Mln – SEC Filing

THOMSON REUTERS
·
21 Mar

BRIEF-Senti Biosciences Files For Shelf Of Up To 52.9 Mln Shares Of Common Stock By Selling Stockholders - SEC Filing

Reuters
·
21 Mar

Senti Biosciences Files for Shelf of up to 52.9 Mln Shares of Common Stock by Selling Stockholders - SEC Filing

THOMSON REUTERS
·
21 Mar

Senti Bio reports Q4 EPS (67c), consensus ($3.13)

TIPRANKS
·
21 Mar